ELV insider transaction filings
Elevance Health, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-09-04. Screen ELV transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 4 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 2 filings by 2 insiders — 3,725 shares, $1,368,280 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 3.
- Largest priced transaction: purchase of 2,045 shares @ $368.25 ($753,071) by BOUDREAUX GAIL, filed 2026-07-17.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| BOUDREAUX GAIL — President and CEO, Director | 1 | 2 legs · 2,725 sh · $1,002,230 | — | — |
| PERU RAMIRO G — Director | 1 | 1 leg · 1,000 sh · $366,050 | — | — |
| Wessling Erin M — EVP & Chief Legal Officer | 1 | — | — | 2 |
| Craig Ryan R — EVP & Chief HR Officer | 1 | — | — | 1 |
Recent Form 4 filings — Elevance Health, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-04 | 4 | Craig Ryan R — EVP & Chief HR Officer | Tax withholding (F): 144 @ $405.84 | EDGAR |
| 2026-09-04 | 4 | Wessling Erin M — EVP & Chief Legal Officer | Tax withholding (F): 94 @ $405.84 · Tax withholding (F): 255 @ $414.78 | EDGAR |
| 2026-07-17 | 4 | BOUDREAUX GAIL — President and CEO, Director | Purchase (P): 680 @ $366.41 · Purchase (P): 2,045 @ $368.25 | EDGAR |
| 2026-07-17 | 4 | PERU RAMIRO G — Director | Purchase (P): 1,000 @ $366.05 | EDGAR |
| 2026-06-15 | 4 | Penczek Ronald W — CAO & Controller | Sale (S): 369 @ $403.16 | EDGAR |
| 2026-06-12 | 4 | Dixon Robert L JR — Director | Sale (S): 151 @ $401.77 | EDGAR |
| 2026-05-20 | 4 | Penczek Ronald W — CAO & Controller | Option exercise (M): 654 @ $271.27 · Option exercise (M): 877 @ $311.48 · Sale (S): 1,531 @ $403.13 · Option exercise (M): 654 (derivative) @ $0 · Option exercise (M): 877 (derivative) @ $0 | EDGAR |
| 2026-05-15 | 4 | Jallal Bahija — Director | Grant/award (A): 563 @ $0 | EDGAR |
| 2026-05-15 | 4 | Neri Antonio F — Director | Grant/award (A): 563 @ $0 | EDGAR |
| 2026-05-15 | 4 | STRABLE-SOETHOUT DEANNA D — Director | Grant/award (A): 563 @ $0 | EDGAR |
| 2026-05-15 | 4 | DeVore Susan D. — Director | Grant/award (A): 563 @ $0 | EDGAR |
| 2026-05-15 | 4 | Dixon Robert L JR — Director | Grant/award (A): 563 @ $0 | EDGAR |
| 2026-05-15 | 4 | SCHULMAN AMY W — Director | Grant/award (A): 563 @ $0 | EDGAR |
| 2026-05-15 | 4 | Schneider Ryan M. — Director | Grant/award (A): 563 @ $0 | EDGAR |
| 2026-05-15 | 4 | PERU RAMIRO G — Director | Grant/award (A): 563 @ $0 | EDGAR |
| 2026-05-15 | 4 | COLLIS STEVEN H — Director | Grant/award (A): 563 @ $0 | EDGAR |
| 2026-05-15 | 4 | HAY LEWIS III — Director | Grant/award (A): 563 @ $0 | EDGAR |
| 2026-03-23 | 4 | SCHULMAN AMY W — Director | Sale (S): 26 @ $287.50 | EDGAR |
| 2026-03-09 | 4 | Kendrick Charles Morgan JR — EVP & President, Commercial | Sale (S): 3,196 @ $284.92 | EDGAR |
| 2026-03-06 | 4 | COLLIS STEVEN H — Director | Purchase (P): 3,000 @ $289.84 | EDGAR |
| 2026-03-04 | 4 | Wessling Erin M — EVP & Chief Legal Officer | Grant/award (A): 2,976 @ $0 · Tax withholding (F): 417 @ $284.03 · Grant/award (A): 11,754 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Craig Ryan R — EVP & Chief HR Officer | Tax withholding (F): 25 @ $294.07 · Grant/award (A): 2,976 @ $0 · Tax withholding (F): 309 @ $284.03 · Grant/award (A): 11,754 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Kendrick Charles Morgan JR — EVP & President, Commercial | Tax withholding (F): 1,211 @ $294.07 · Grant/award (A): 4,017 @ $0 · Grant/award (A): 2,532 @ $0 · Tax withholding (F): 467 @ $284.03 · Grant/award (A): 15,870 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Kaye Mark — EVP & CFO | Tax withholding (F): 271 @ $294.07 · Grant/award (A): 6,377 @ $0 · Grant/award (A): 10,202 @ $0 · Tax withholding (F): 353 @ $284.03 · Grant/award (A): 25,188 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Norwood Felicia F — EVP &Chief Health Benefits Ofr | Tax withholding (F): 1,421 @ $294.07 · Grant/award (A): 5,951 @ $0 · Grant/award (A): 2,865 @ $0 · Tax withholding (F): 496 @ $284.03 · Grant/award (A): 23,512 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | LAVU RATNAKAR — EVP & Chief Digital Info Ofr | Tax withholding (F): 315 @ $294.07 · Grant/award (A): 5,101 @ $0 · Grant/award (A): 6,802 @ $0 · Tax withholding (F): 222 @ $284.03 · Grant/award (A): 20,152 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Penczek Ronald W — CAO & Controller | Tax withholding (F): 131 @ $294.07 · Grant/award (A): 426 @ $0 · Grant/award (A): 1,701 @ $0 · Grant/award (A): 266 @ $0 · Tax withholding (F): 37 @ $284.03 · Grant/award (A): 1,677 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Haytaian Peter D — EVP & Pres Carelon & CarelonRx | Tax withholding (F): 1,201 @ $294.07 · Grant/award (A): 2,865 @ $0 · Tax withholding (F): 446 @ $284.03 | EDGAR |
| 2026-03-04 | 4 | BOUDREAUX GAIL — President and CEO, Director | Tax withholding (F): 6,713 @ $294.07 · Grant/award (A): 16,153 @ $0 · Grant/award (A): 10,527 @ $0 · Tax withholding (F): 1,736 @ $284.03 · Grant/award (A): 63,818 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4 | Craig Ryan R — EVP & Chief HR Officer | Tax withholding (F): 279 @ $341.83 | EDGAR |
| 2026-02-03 | 4 | SCHULMAN AMY W — Director | Grant/award (A): 218 @ $0 | EDGAR |
| 2025-10-03 | 4 | Kaye Mark — EVP & CFO | Tax withholding (F): 2,895 @ $340.24 | EDGAR |
| 2025-09-05 | 4 | Wessling Erin M — EVP & Chief Legal Officer | Tax withholding (F): 152 @ $321.59 | EDGAR |
| 2025-09-04 | 4 | Wessling Erin M — EVP & Chief Legal Officer | Grant/award (A): 931 @ $0 · Grant/award (A): 3,541 (derivative) @ $0 | EDGAR |
| 2025-09-04 | 4 | Craig Ryan R — EVP & Chief HR Officer | Grant/award (A): 970 @ $0 · Grant/award (A): 3,690 (derivative) @ $0 | EDGAR |
| 2025-08-21 | 4 | DeVore Susan D. — Director | Purchase (P): 1,200 @ $312.15 | EDGAR |
| 2025-08-05 | 4 | COLLIS STEVEN H — Director | Grant/award (A): 639 @ $0 | EDGAR |
| 2025-07-18 | 4 | BOUDREAUX GAIL — President and CEO, Director | Purchase (P): 2,334 @ $286.07 · Purchase (P): 5,116 @ $287.12 · Purchase (P): 1,050 @ $287.96 | EDGAR |
| 2025-05-16 | 4 | CLARK R KERRY — Director | Grant/award (A): 601 @ $0 | EDGAR |
| 2025-05-16 | 4 | STRABLE-SOETHOUT DEANNA D — Director | Grant/award (A): 601 @ $0 | EDGAR |
| 2025-05-16 | 4 | Schneider Ryan M. — Director | Grant/award (A): 601 @ $0 | EDGAR |
| 2025-05-16 | 4 | PERU RAMIRO G — Director | Grant/award (A): 601 @ $0 | EDGAR |
| 2025-05-16 | 4 | Neri Antonio F — Director | Grant/award (A): 601 @ $0 | EDGAR |
| 2025-05-16 | 4 | Jallal Bahija — Director | Grant/award (A): 601 @ $0 | EDGAR |
| 2025-05-16 | 4 | HAY LEWIS III — Director | Grant/award (A): 601 @ $0 | EDGAR |
| 2025-05-16 | 4 | Dixon Robert L JR — Director | Grant/award (A): 601 @ $0 | EDGAR |
| 2025-05-16 | 4 | DeVore Susan D. — Director | Grant/award (A): 601 @ $0 | EDGAR |
| 2025-04-25 | 4 | Kaye Mark — EVP & CFO | Sale (S): 4,588 @ $424.82 | EDGAR |
| 2025-03-11 | 4 | Penczek Ronald W — CAO & Controller | Sale (S): 443 @ $415.13 | EDGAR |
| 2025-03-05 | 4 | BOUDREAUX GAIL — President and CEO, Director | Tax withholding (F): 10,396 @ $395.50 · Grant/award (A): 10,620 @ $0 · Grant/award (A): 15,587 @ $0 · Grant/award (A): 40,429 (derivative) @ $0 | EDGAR |
Recent 8-K events — Elevance Health, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-10 | 8-K | 7.01 — Regulation FD Disclosure | EDGAR |
| 2026-07-15 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-10 | 8-K | 7.01 — Regulation FD Disclosure | EDGAR |
| 2026-05-13 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-04-22 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-10 | 8-K | 7.01 — Regulation FD Disclosure | EDGAR |
| 2026-03-02 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-02-26 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure | EDGAR |
| 2026-01-28 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-10 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ELV returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →